Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Couñago F.
- González C.
- Gómez-Iturriaga A.
- Álvarez A.
- Santos M.
- Boladeras A.
- García N.
- Fernández S.
- Guardado S.
- Ocanto A.
- Gonsalves D.
- Glaría L.
- Castaño A.
- Martín P.
- Montezuma L.
- Mera A.
- Mases J.
- Meca G.
- Duque-Santana V.
- Olivera J.
- Pérez S.
- Henriquez I.
- Malavé B.
- Rodríguez A.
- García R.
- Büchser D.
- Garre J.
- Altabas M.
- Valero J.
- Calvo Á.
- Ordoñez R.
- Willisch P.
- Candal A.
- Aymar N.
- Mayrata E.
- López-Campos F.
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 2405-6308, 2405-6308
- Tipo:
- Article
- Páginas:
- -
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,363 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Clinical and Translational Radiation Oncology ELSEVIER IRELAND LTD
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- bicalutamide; goserelin; leuprorelin; triptorelin; adverse event; aged; androgen deprivation therapy; Article; biochemical recurrence; bone scintiscanning; cancer specific survival; computer assisted tomography; controlled study; diabetes mellitus; European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; feces incontinence; fractionation; gastrointestinal disease; heart disease; hematuria; human; hypertension; hypofractionated radiotherapy; intensity modulated radiation therapy; kidney disease; liver disease; lung disease; major clinical study; metastasis free survival; overall survival; patient-reported outcome; peripheral arterial disease; phase 3 clinical trial; planning target volume; positron emission tomography; progression free survival; prostatectomy; randomized controlled trial; rectum hemorrhage; recurrence free survival; salvage radiotherapy; salvage therapy; tenesmus; tomotherapy; urethra stenosis; urine incontinence; urine retention
Cita
Couñago F,González C,Gómez A,Álvarez A,Santos M,Boladeras A,García N,Fernández S,Guardado S,Ocanto A,Gonsalves D,Glaría L,Castaño A,Martín P,Montezuma L,Mera A,Mases J,Meca G,Duque V,Olivera J,Pérez S,Henriquez I,Malavé B,Rodríguez A,García R,Büchser D,Garre J,Altabas M,Valero J,GARCÍA R,BERENGUER M,Calvo Á,Ordoñez R,Willisch P,Candal A,Aymar N,Mayrata E,López F. Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial. Clin. Transl. Radiat. Oncol. 2026. 61. 101276. IF:3,600. (1).
Portal de investigación